VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
+18.72%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$512M
AUM Growth
+$512M
(-14%)
Cap. Flow
-$23M
Cap. Flow
% of AUM
-4.49%
Top 10 Holdings %
Top 10 Hldgs %
73.66%
Holding
32
New
4
Increased
5
Reduced
2
Closed
7
Top Buys
| 1 |
Enliven Therapeutics
ELVN
|
$48.5M |
| 2 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$29.4M |
| 3 |
Pliant Therapeutics
PLRX
|
$9.31M |
| 4 |
Cogent Biosciences
COGT
|
$9.14M |
| 5 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$6.84M |
Top Sells
| 1 |
Axsome Therapeutics
AXSM
|
$51.7M |
| 2 |
Aclaris Therapeutics
ACRS
|
$28.5M |
| 3 |
Novavax
NVAX
|
$19.3M |
| 4 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$11.8M |
| 5 |
LIAN
LianBio American Depositary Shares
LIAN
|
$7.86M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVB
26
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| – | – |
-1,118,653
| Closed | -$11.8M |
|
|
LIAN
27
DELISTED
LianBio American Depositary Shares
LIAN
| – | – |
-4,793,047
| Closed | -$7.86M |
|
|
28
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-670,718
| Closed | -$51.7M |
|
|
INZY
29
DELISTED
Inozyme Pharma
INZY
| – | – |
-2,709,987
| Closed | -$2.85M |
|
|
30
Novavax
NVAX
$1.2B
| – | – |
-1,879,894
| Closed | -$19.3M |
|
|
ATYR
31
aTyr Pharma
ATYR
$560M
| – | – |
-1,171,436
| Closed | -$2.57M |
|
|
MRNS
32
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-1,770,705
| Closed | -$7.05M |
|